Testing new immune cells on breast cancer samples in the lab
Part of Cancer, Skin clinical trials.
This trial studies whether newly made immune cells (“CAR-macrophages”) can attack breast cancer when tested on your tumor samples grown in the lab (“organoids”). If you need surgery or a tumor biopsy as part of your usual care, your sample may be used to test this approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have breast cancer confirmed by pathology (a tissue test)
- You are scheduled to have surgery or a tumor biopsy as standard care
- You may be on treatment already or not (either is okay)
- You are willing to sign informed consent
- You have health insurance coverage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial builds lab “models” (called organoids) from breast cancer tissue to help researchers study different breast cancer types. You may be able to help by providing consent and meeting the study’s basic cancer and treatment history requirements.
This trial collects immune cells from cancer patients or healthy volunteers to develop new experimental cancer treatments. Researchers will take a sample of your tumor or blood cells, grow them in the lab, and study how to use them to fight your cancer.
This study uses a sample of your tumor to grow a mini-tumor in the lab (called an organoid) to see which chemotherapy might work best for you. This could help reduce the chance of cancer coming back after treatment.
This study is testing a new way to understand your breast cancer by growing tiny tumor samples (called organoids) in the lab. It will help researchers learn more about your cancer type and could lead to better treatments.
This study looks at how your immune system changes while you receive standard breast cancer treatments. The researchers measure immune-related signals during your treatment to better understand what may be happening in triple-negative or certain hormone-receptor breast cancers.
This trial tests a personalized immune-cell treatment (CAR T) built from your own blood lymphocytes. It targets cancers that show a marker called CD70, aiming to slow or stop the cancer when other treatments didn’t work.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.